A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF10073 After Single and Multiple Doses in Healthy Volunteers and the Effect of Itraconazole on CHF10073 Exposure
Clinical trial NCT06746064 · COMPLETED
Trial details
- NCT number
- NCT06746064
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-13
- Primary completion
- 2026-02-04
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.